摘要:
A CD154 binding molecule, in particular an antibody to human CD154, especially a human antibody to human CD154 is provided, wherein the CDRs of the heavy chain and light chain have amino acid sequences as defined, for use in the treatment and/or prevention of diseases or disorders wherein CD154 modulation and/or interference with or inhibition of the CD154:CD40 interactions is therapeutically beneficial.
摘要:
The use of (A) a polypeptide comprising the amino acid sequence of SEQ ID NO:2, or a functionally equivalent variant of that amino acid sequence, or (B) a polynucleotide comprising a nucleotide sequence encoding the polypeptide (A), or (C) an antibody which is immunoreactive with the polypeptide (A), or (D) an antisense oligonucleotide comprising a nucleotide sequence complementary to that of polynucleotide (B), or (E) a polynucleotide probe comprising at least 15 consecutive nucleotides of (B), in the preparation of a pharmaceutical for the diagnosis or treatment of a neutrophil-associated inflammatory disease.
摘要:
A single colony of myxobacterium cells, a process for its production and its use. A process for the production of a myxobacterium Sorangium strain (Sorangium cellulosum) having an improved epothilone production rate. A process for the production of epothilone B using the aforementioned strain. A process for the production of single colonies of myxobacteria comprising cultivating myxobacteria on a nutrient medium containing isoleucin and/or leucin.
摘要:
The present invention relates to a process for the manufacture of a porous polymer, wherein a composition comprising a polymerizable component, a porogen having an inverse temperature dependent solubility and a solvent are polymerized at a temperature around the cloud point temperature of the composition. The porous polymers obtainable according to the process of the invention are useful, for example, as materials for the manufacture of biomedical devices and prostheses, including ophthalmic devices such as contact lenses or artificial corneas.
摘要:
The present invention is related to the use of an ophthalmic composition comprising ketotifen in the preparation of an eye medicament for the treatment allergic conjunctivitis of contact lens wearers.
摘要:
An active ingredient combination for the simultaneous control of ecto- and endoparasites, especially mites, ticks and nematodes, on productive livestock, domestic animals and pets, is described, which comprises the active ingredients (1) 1-[4-chloro-3-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl]-3-(2,6-difluorobenzoyl)urea and (2) a compound of formula (i) wherein R1 is hydrogen or one of radicals (ii) or (iii), R2 is CH(CH3)-CH3, -CH(CH3)-C2H5, -C(CH3)=CH-CH(CH3)2 or cyclohexyl; R3 is hydrogen or hydroxy if the bond between atoms 22 and 23 represents a double bond, or is hydrogen or the group =N-O-CH3 if a single bond is present between atoms 22 and 23; and R4 is HO- or HO-N=, in free form or in the form of a physiologically acceptable salt.
摘要:
This invention is directed to ophthalmic materials and ophthalmic lenses that are a co-polymerization product of a (a) hydrophilic monomer with (b) a tris(siloxy)silyl group-containing monomer, (c) a wide variety of hydrophobic monomers (both aliphatic and aromatic) and usually a (d) polyfluorinated monomer, as well as optional monomers or monomer mixtures that can include a cationic monomer, a non-aromatic hydrophobic monomer and a poly(dimethylsiloxy)silyl group-containing monomer. A contact lens prepared from such a co-polymer exhibits enhanced water content, while maintaining exceptional oxygen permeability, thereby providing a lens that can be worn comfortably for prolonged periods of time. A process for the preparation of such lenses is also disclosed.
摘要:
The preparation of an improved galenic delivery form of valnemulin, which is notable for its good tolerance and stability in storage, is described. The new delivery form in question is a non-aqueous or oily injection formulation, which is obtainable by means of in situ preparation and subsequent stabilisation of the free, relatively unstable base of the active ingredient. A further aspect of the present invention concerns the usage of such an injection formulation in a method of treating infectious diseases in productive livestock or domestic animals.
摘要:
A method of successfully controlling sea lice in commercial fish farming, in an efficient and environmentally friendly way, with the compounds named in claim 1, (i.e. benzoyl urea derivatives) preferably by injection, and a method of automating this type of control, are described.